title: Pathologic changes and contractile properties of the diaphragm in corticosteroid myopathy in hamsters: comparison to peripheral muscle.
abstract: Corticosteroids have been shown to produce a myopathy of peripheral skeletal muscle, characterized predominantly by Type II fiber atrophy. To determine if similar histologic and histochemical changes occur in the diaphragm and whether the in vitro contractile properties of this muscle are adversely affected by steroids, we studied two groups of hamsters. The experimental group received triamcinolone while a control group received saline, both given daily for 3 wk as i.m. injections. Soleus (Sol) and extensor digitorum longus (EDL) muscles and costal diaphragm muscle sections were stained for histologic (hematoxylin and eosin, modified Gomori trichrome) and histochemical (myosin ATPase, succinate dehydrogenase [SDH]) analysis. Muscle fiber proportions and cross-sectional areas (CSA) were measured from myosin ATPase sections. In vitro studies of isometric contractions were carried out on small strips of costal diaphragm, measuring maximal isometric twitch (Pt) and tetanus (Po) tensions, time to peak tension (TTP), half relaxation time (1/2 RT), force-frequency relationship, and fatigue characteristics (60 Hz tetani; duty cycle, 0.5). Triamcinolone treatment resulted in no change in muscle fiber proportions. There was no effect on Type I fiber CSA; however, there was Type IIa (Sol, EDL) and Type IIb (diaphragm, EDL) fiber atrophy in triamcinolone-treated animals. Pt and Po (normalized for weight) of diaphragm strips were not different. There was a prolongation in TTP and 1/2 RT, a left shift in the force-frequency curve, and a reduced fatiguability of triamcinolone-treated diaphragm (P less than 0.05). We conclude that a steroid myopathy could be explained by a loss of muscle mass (Type IIb fiber atrophy) rather than an intrinsic impairment in contractile function.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, B.C., Canada.
authors.forename: P G
authors.initials: PG
authors.lastname: Wilcox
authors.forename: J M
authors.initials: JM
authors.lastname: Hards
authors.forename: K
authors.initials: K
authors.lastname: Bockhold
authors.forename: B
authors.initials: B
authors.lastname: Bressler
authors.forename: R L
authors.initials: RL
authors.lastname: Pardy
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D006224:Cricetinae; D003964:Diaphragm / Q000473:pathology / Q000503:physiopathology; D008647:Mesocricetus; D009119:Muscle Contraction; D009132:Muscles / Q000033:anatomy & histology / Q000473:pathology / Q000503:physiopathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D009929:Organ Size / Q000187:drug effects; D014221:Triamcinolone / Q000633:toxicity*
chemical_list: D014221:Triamcinolone